Pharmacopsychiatry 2010; 43(5): 174-178
DOI: 10.1055/s-0030-1249095
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Finasteride Treatment Inhibits Adult Hippocampal Neurogenesis in Male Mice

B. Römer1 , N. Pfeiffer1 , S. Lewicka2 , N. Ben-Abdallah1 , M. A. Vogt1 , M. Deuschle1 , B. Vollmayr1 , P. Gass1
  • 1RG Behavioural Biology, Central Institute of Mental Health, Mannheim, University of Heidelberg, Germany
  • 2Department of Pharmacology, University of Heidelberg, Germany
Further Information

Publication History

received 02.06.2009 revised 27.01.2010

accepted 29.01.2010

Publication Date:
18 May 2010 (online)

Preview

Abstract

Introduction: The 5-alpha-reductase inhibitor finasteride is used for the treatment of androgenic alopecia, benign prostate hyperplasia and prostate cancer. Besides inhibiting the conversion of testosterone to the biologically more active 5α-dihydrotestosterone, it also inhibits the production of neurosteroids. Decreased neurosteroid levels are postulated to be involved in the pathophysiology of psychiatric disorders such as depression. As neurosteroids metabolized by 5-alpha-reductase influence neural plasticity, we investigated whether finasteride treatment alters adult hippocampal neurogenesis, implicated in the pathophysiology of depression.

Methods: Male C57BL/6N mice were treated subchronically (7 days) with finasteride or vehicle. Adult neurogenesis was assessed at two different time points after treatment (day 1; day 35) using immunohistochemistry.

Results: Finasteride treatment led to a significant decrease in brain 5α-dihydrotestosterone levels and induced a reversible reduction in the number of newborn cells and young neurons in the hippocampus. 35 days after the last finasteride injection, neurogenesis had returned to normal.

Discussion: These data indicate that inhibition of 5-alpha-reductase activity by finasteride treatment influences neuronal plasticity on a structural level. These changes might contribute to the pathophysiology of depressive episodes observed after finasteride treatment.

References

Correspondence

B. RömerMD 

Central Institute of

Mental Health

J5

68159 Mannheim

Germany

Phone: +49/621/17 030

Email: benedikt.roemer@zi-mannheim.de